1 |
YOKOTA T,URA T,SHIBATA N,et al.BRAF mutaion is a powerful prognostic factor in advanced and recurrent colorectal cancer[J]. Br J Cancer,2011,104(5):856-862.
|
2 |
GAO J,LI Y Y,SUN P N,et al.Comparative analysis of dideoxy sequencing,the KRAS StripAssay and pyrosequencing for detection of KRAS mutation[J]. World J Gastroenterol,2010,16(38):4858-4864.
|
3 |
ZHANG L,YANG H,ZHAO Y,et al.Detection of EGFR somatic mutations in non-small cell lung cancer(NSCLC) using a novel mutant-enriched liquidchip(MEL) technology[J]. Curr Drug Metab,2012,13(7):1007-1011.
|
4 |
CERNOMAZ A T,MACOVEI L L,PAVEL L,et al.Comparison of next generation sequencing, SNaPahot assay and real-time ploymerase chain reaction for lung adenocarcinoma EGFR muation assessment[J]. BMC Pulm Med,2016,16(1):88.
|
5 |
WEI M,YU Z,ZHANG H.Molecular characterization of microbial communities in bioaerosols of a coal mine by 454 pyrosequencing and real-time PCR[J]. J Environ Sci(China),2015,30:241-251.
|
6 |
YAEGER R,CERCEK A,CHOU J F,et al.BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer[J]. Cancer,2014,120(15):2316-2324.
|
7 |
CHO M,AKIBA C,LAU C,et al.Impact of RAS and BRAF mutations on carcinoembryonic antigen production and pattern of colorectal metastases[J]. World J Gastrointest Oncol,2016,8(1):128-135.
|
8 |
SIEGEL R,MA J M,ZOU Z H,et al.Cancer statistics,2014[J]. CA Cancer J Clin,2014,64:9-29.
|
9 |
易文君,钟德玝,邹琼燕. BRAF基因突变与甲状腺乳头状癌的相关性[J]. 中南大学学报(医学版),2012,37(4):370-373.
|
10 |
朱琰琰,斯璐,迟志宏,等. 中国黑色素瘤患者BRAF基因突变分析[J]. 临床肿瘤学杂志,2009,14(7):585-588.
|
11 |
ZHENG L,ZHAO M,HU X Y,et al.Clinical significance of HBME-1,Galectin-3,and CK19 expression and the status of BRAF mutation in papillary thyroid carcinoma[J]. Oncol Transl Med,2016,2(4):174-178.
|
12 |
杨宁,郭妹,宋玉兰,等. 430例中国非小细胞肺癌患者EGFR、KRAS、BRAF和PIK3CA基因突变状态及其临床意义[J]. 中国肿瘤生物治疗杂志,2015,22(6):734-739.
|
13 |
凌云,胡海燕,邱田,等. 结直肠癌患者KRAS和BRAF突变检测及其临床意义[J]. 中国肿瘤临床与康复,2016,23(6):645-649.
|
14 |
万子睿,谢海棠,郭栋,等. 焦磷酸测序技术检测SLCO1B1基因多态性方法的建立[J]. 中国临床药理学与治疗学, 2012,17(5):543-548.
|